Surgical resection with and without chemotherapy in oesophageal cancer

Lancet. 2002 Oct 12;360(9340):1173-4; author reply 1175. doi: 10.1016/S0140-6736(02)11218-9.
No abstract available

Publication types

  • Comment
  • Comparative Study
  • Letter

MeSH terms

  • Adenocarcinoma / drug therapy*
  • Adenocarcinoma / mortality
  • Adenocarcinoma / surgery
  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Carcinoma, Squamous Cell / drug therapy*
  • Carcinoma, Squamous Cell / mortality
  • Carcinoma, Squamous Cell / surgery
  • Cisplatin / administration & dosage
  • Cisplatin / adverse effects
  • Combined Modality Therapy
  • Esophageal Neoplasms / drug therapy*
  • Esophageal Neoplasms / mortality
  • Esophageal Neoplasms / surgery
  • Esophagectomy*
  • Fluorouracil / administration & dosage
  • Fluorouracil / adverse effects
  • Humans
  • Multicenter Studies as Topic
  • Neoadjuvant Therapy*
  • Randomized Controlled Trials as Topic
  • Survival Rate

Substances

  • Cisplatin
  • Fluorouracil